Related Experiment Video
Updated: Aug 20, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Inflammation and vascular calcification
1Indiana University and Roudebush Veterans Affairs Medical Center, Indianapolis, IN 46260, USA. smoe@iupui.edu
Insights
Chronic kidney disease (CKD) patients experience significant vascular calcification and inflammation, increasing morbidity and mortality. Inflammation accelerates calcification by reducing protective fetuin-A levels in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Background:
- Vascular calcification and inflammation are prevalent in chronic kidney disease (CKD).
- CKD patients, especially those on dialysis, exhibit higher rates of coronary and peripheral artery calcification than the general population.
- Both intimal and medial vascular calcification in CKD are linked to increased morbidity and mortality.
Purpose of the Study:
- To explore the mechanisms linking inflammation and vascular calcification in chronic kidney disease.
- To understand how uremic serum induces vascular smooth muscle cell transformation into osteoblast-like cells.
- To investigate the role of inflammatory mediators and fetuin-A in CKD-related vascular calcification.
Main Methods:
- Review of existing literature on vascular calcification and inflammation in CKD.
- Analysis of the cellular processes involved in vascular calcification.
- Examination of the impact of uremic serum and inflammatory mediators on vascular cells.
Main Results:
- Vascular calcification in CKD is an active, cell-mediated process involving vascular smooth muscle cell transformation.
- Inflammatory mediators like oxidation, carbonyl stress, C-reactive protein, and cytokines may directly promote vascular calcification.
- Inflammation reduces fetuin-A, a key inhibitor of vascular calcification, exacerbating mineral deposition.
Conclusions:
- The uremic environment in CKD promotes vascular calcification through accelerated processes and impaired defense mechanisms.
- Inflammation plays a critical role in driving vascular calcification in CKD by both direct stimulation and reduction of inhibitors.
- Understanding these mechanisms is crucial for managing cardiovascular complications in CKD patients.
Abstract:
Both vascular calcification and inflammation are common in patients with chronic kidney disease (CKD). In patients on dialysis, there is increased coronary artery and peripheral artery calcification compared to the general population. Both intimal (atherosclerotic) and medial calcification in CKD patients are associated with increased morbidity and mortality. Vascular calcification is an active cell-mediated process, and likely reflects a transformation of vascular smooth muscle cells to osteoblast-like cells. Pooled uremic serum can induce this transformation, but the mechanism by which it does so is not yet clear. Several mediators of inflammation such as oxidation, carbonyl stress, C-reactive protein, and cytokines may directly stimulate vascular calcification. In addition, inflammation itself reduces fetuin-A, a naturally occurring inhibitor of vascular calcification which binds excess mineral in serum. The combination of the acceleration of vascular calcification together with impaired defense mechanisms creates a uremic milieu primed for extra-osseous calcification.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Acute Inflammation III: Local and Systemic Effects
Inflammation: Introduction
Coronary Artery Disease II: Pathophysiology
Chronic Inflammation: Introduction

